SEARCH RESULTS FOR: "Tag: acor"
REFINE YOUR SEARCH:
ARTICLES/BLOGS
2018(7)
2017(8)
2016(1)
2015(1)
CATEGORIES
Analyst Update(1)
Buzz Stocks(7)
Intraday Option Activity(1)
Midday Market Check(1)
Opening View(6)
Stocks On the Move(2)

12/24/2018 11:32 AM
Acorda Therapeutics (NASDAQ:ACOR) shares are up 5% at $13.59 today, lifted by Friday's late-breaking news that the Food and Drug Administration (FDA) approved its new Parkinson's drug. The inhalable t...
12/24/2018 9:11 AM
It's an abbreviated session on Wall Street today, with the stock market closing at 1 p.m. ET for the Christmas holiday, and shuttered all day tomorrow. Traders are less than cheerful, with Dow Jone...
12/11/2018 11:33 AM
The shares of Acorda Therapeutics Inc (NASDAQ:ACOR) are spiraling today, after Goldman Sachs downgraded the drug stock to "sell" from "neutral," and nearly halved its price target to $10 from $19 -- ...
10/5/2018 12:06 PM
U.S. stocks are suffering notable losses at midday, as bond yields continue to rise on the back of this morning's jobs data. The S&P 500 Index (SPX) is heading toward its first close below 2,900 ...
9/13/2018 10:23 AM
Drugmakers Acorda Therapeutics Inc (NASDAQ:ACOR) and Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) have fallen near the bottom of the Nasdaq this morning, after both were dealt crippling blows to the...

Welcome to Schaeffer's Investment Research! We are a privately held provider of stock and options trading recommendations, options education, and market commentary, headquartered in Cincinnati, Ohio. Founded in 1981 by industry pioneer Bernie Schaeffer, we've since become a trusted source of research and analysis for individual investors and major financial media outlets alike.







Partner Center